姜黄素逆转P-糖蛋白介导的多药耐药机制

doi:10.3760/cma.j.issn.1673-422X.2017.10.009

摘要/Abstract

摘要： 多药耐药（MDR）是临床药物抗癌失败的重要原因之一，涉及多种机制。其中，P糖蛋白（Pgp）介导的经典MDR机制与MDR的形成关系密切，通过“药泵”效应排出细胞内化疗药物，显著降低化疗疗效。姜黄素主要提取自中药姜黄的地下根茎，具有广泛的药理活性。近年研究发现，姜黄素通过调控多种信号通路，抑制Pgp的功能和表达，发挥逆转肿瘤MDR的作用。

关键词: 姜黄素, P糖蛋白, 多药耐药, 信号通路

Abstract: Multidrug resistance (MDR) is one of the important reasons for the failure of clinical anticancer drugs, involving multiple mechanisms. Among them, the classical MDR mechanism mediated by Pglycoprotein (Pgp) is closely related to the formation of MDR, which can excrete intracellular chemotherapeutic drugs through the "drug pump" effect and significantly reduce the therapeutic effect. Curcumin is mainly extracted from the underground rhizome of Chinese medicine turmeric, with a wide range of pharmacological activity. Recent studies have found that curcumin also has a role in reversing the MDR of the tumor, by inhibiting both Pgp function and expression, and this process involves a variety of signal paths.

Key words: Curcumin, P-glycoprotein, Multidrug resistance, Signal path

刘兰,张志敏,彭文苗,付红星,饶智国. 姜黄素逆转P-糖蛋白介导的多药耐药机制[J]. 国际肿瘤学杂志, 2017, 44(10): 758-761.

Liu Lan, Zhang Zhimin, Peng Wenmiao, Fu Hongxing, Rao Zhiguo. Reversal of Pglycoproteinmediated multidrug resistance mechanism by curcumin[J]. Journal of International Oncology, 2017, 44(10): 758-761.

参考文献

［1］ Wu Q, Yang Z, Nie Y, et al. Multidrug resistance in cancer chemotherapeutics: mechanisms and lab approaches［J］. Cancer Lett, 2014, 347(2): 159166. DOI: 10.1016/j.canlet.2014.03.013. ［2］ Silva R, VilasBoas V, Carmo H, et al. Modulation of Pglycoprotein efflux pump: induction and activation as a therapeutic strategy［J］. Pharmacol Ther, 2015, 149(2): 1123. DOI: 10.1016/j.pharmthera.2014.11.013. ［3］ Loo TW, Clarke DM. PGlycoprotein ATPase activity requires lipids to activate a switch at the first transmission interface［J］. Biochem Biophys Res Commun, 2016, 472(2): 379383. DOI: 10.1016/j.bbrc.2016.02.124. ［4］ Bugde P, Biswas R, Merien F, et al. The therapeutic potential of targeting ABC transporters to combat multidrug resistance［J］. Expert Opin Ther Targets, 2017, 21(5): 511530. DOI: 10.1080/14728222.2017.1310841. ［5］ Teng YN, Hsieh YW, Hung CC, et al. Demethoxycurcumin modulates human Pglycoprotein function via uncompetitive inhibition of ATPase hydrolysis activity［J］. J Agric Food Chem, 2015, 63(3): 847855. DOI: 10.1021/jf5042307. ［6］ Sreenivasan S, Ravichandran S, Vetrivel U, et al. Modulation of multidrug resistance 1 expression and function in retinoblastoma cells by curcumin［J］. J Pharmacol Pharmacother, 2013, 4(2): 103109. DOI: 10.4103/0976500X.110882. ［7］ Prasad N, Sudhakar YA, Kanwar JR. Curcumin regulates colon cancer by inhibiting Pglycoprotein in insitu cancerous colon perfusion rat model［J］. J Cancer Sci Ther, 2014, 5(9): 313319. DOI: 10.4172/19485956.1000221. ［8］ Shah K, Mirza S, Desai U, et al. Synergism of curcumin and cytarabine in the down regulation of multidrug resistance genes in acute myeloid leukemia［J］. Anticancer Agents Med Chem, 2016, 16(1): 128135. DOI: 10.2174/1871520615666150817115718. ［9］ Si M, Zhao J, Li X, et al. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of Pglycoprotein［J］. Chin Med J, 2013, 126(21): 41164123. DOI: 10.3760/cma.j.issn.03666999.20130950. ［10］ Yao J, Wei X, Lu Y. Chaetominine reduces MRP1mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells［J］. Biochem Biophys Res Commun, 2016, 473(4): 867873. DOI: 10.1016/j.bbrc.2016.03.141. ［11］ Wang L, Wang C, Jia Y, et al. Resveratrol increases antiproliferative activity of bestatin through downregulating Pglycoprotein expression via inhibiting PI3K/Akt/mTOR pathway in K562/ADR cells［J］. J Cell Biochem, 2015, 117(5): 12331239. DOI: 10.1002/jcb.25407. ［12］ Barancík M, Bohácová V, Sedlák J, et al. LY294, 002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes Pglycoproteinmediated multidrug resistance［J］. Eur J Pharm Sci, 2006, 29(5): 426434. DOI: 10.1016/j.ejps.2006.08.006. ［13］ Choi BH, Kim CG, Lim Y, et al. Curcumin downregulates the multidrugresistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway［J］. Cancer Lett, 2008, 259(1): 111118. DOI: 10.1016/j.canlet.2007.10.003. ［14］金鑫. 姜黄素联合吉非替尼对非小细胞肺癌NCIH1975作用及机制研究［D］. 杭州: 浙江大学, 2016. ［15］ Zhang X, Xiao W, Wang L, et al. Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via downregulating Pgp［J］. PLoS One, 2011, 6(6): e20965. DOI: 10.1371/journal.pone.0020965. ［16］ Ji T, Gong D, Han Z, et al. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer［J］. Cancer lett, 2013, 341(2): 231239. DOI: 10.1016/j.canlet.2013.08.022. ［17］ Wen K, Fu Z, Wu X, et al. Oct4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/Survivin［J］. Cancer Lett, 2013, 333(1): 5665. DOI: 10.1016/j.canlet.2013.01.009. ［18］文坤明, 冷敏, 程家平, 等. 姜黄素通过抑制STAT3通路调控人结肠癌耐奥沙利铂细胞株的耐药性［J］. 中国免疫学杂志, 2015(8): 10561059. DOI: 10.3969/j.issn.1000484X.2015.08.012. ［19］ Zhang W, Guo J, Li S, et al. Discovery of monocarbonyl curcuminBTP hybrids as STAT3 inhibitors for drugsensitive and drugresistant breast cancer therapy［J］. Sci Rep, 2017, 7: 46352. DOI: 10.1038/srep46352. ［20］ Guan H, Zhao P, Dai Z, et al. SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/Pglycoprotein via EGFR/ERK/AP1 pathway［J］. Tumour Biol, 2016, 37(9): 1215312160. DOI: 10.1007/s1327701650920. ［21］ Guo X, Ma N, Wang J, et al. Increased p38MAPK is responsible for chemotherapy resistance in human gastric cancer cells［J］. BMC Cancer, 2008, 8: 375. DOI: 10.1186/147124078375. ［22］王志君. 姜黄素对紫杉醇耐药卵巢癌细胞SKOV3/Taxol25的逆转增效作用及其机理的研究［D］. 苏州: 苏州大学, 2015. ［23］ Chen P, Li J, Jiang HG, et al. Curcumin reverses cisplatin resistance in cisplatinresistant lung caner cells by inhibiting FA/BRCA pathway［J］. Tumour Biol, 2015, 36(5): 35913599. DOI: 10.1007/s1327701429964. ［24］ Liang Y, Zheng T, Song R, et al. Hypoxiamediated sorafenib resistance can be overcome by EF24 through Von HippelLindau tumor suppressordependent HIF1α inhibition in hepatocellular carcinoma［J］. Hepatology, 2013, 57(5): 18471857. DOI: 10.1002/hep.26224. ［25］ Muddineti OS, Kumari P, Ghosh B, et al. dαTocopheryl succinate/phosphatidyl ethanolamine conjugated amphiphilic polymerbased nanomicellar system for the efficient delivery of curcumin and to overcome multiple drug resistance in cancer［J］. ACS Appl Mater Interfaces, 2017, 9(20): 1677816792. DOI: 10.1021/acsami.7b01087.

[1]	胡茹, 李东霖, 严雪冰. 甲基转移酶样蛋白14与肿瘤[J]. 国际肿瘤学杂志, 2022, 49(8): 478-483.
[2]	罗盼, 曾艳, 吴伟莉. JAK2-STAT3信号通路在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2021, 48(12): 739-742.
[3]	李珂珂, 孔盼盼, 易超, 王喜艳, 晏冬. 淋巴样增强因子-1在胰腺导管腺癌中的表达及对预后的影响[J]. 国际肿瘤学杂志, 2021, 48(10): 608-613.
[4]	翟婧彤, 马飞. 恶性肿瘤中BCL9的功能及其靶向治疗研究[J]. 国际肿瘤学杂志, 2020, 47(7): 419-422.
[5]	李钰祥, 王新文. 干扰素治疗肿瘤相关的信号通路及临床应用[J]. 国际肿瘤学杂志, 2020, 47(6): 364-367.
[6]	顾思佳，孙国壮，乔大伟，仲毅，孔桂美，卜平. Hippo信号通路与结直肠癌[J]. 国际肿瘤学杂志, 2019, 46(5): 299-302.
[7]	王昭,王迎难,倪吉祥,朱晶. Hippo信号通路及其在非小细胞肺癌中的表达和作用[J]. 国际肿瘤学杂志, 2019, 46(4): 239-242.
[8]	邢紫阳, 孙春霞. 胃癌分子信号通路与癌性疼痛[J]. 国际肿瘤学杂志, 2019, 46(12): 755-759.
[9]	凌晓斐，胥可，邵华，王翠娟. 姜黄素类似物EF24的抗肿瘤机制与应用 [J]. 国际肿瘤学杂志, 2018, 45(3): 172-175.
[10]	夏得淳,康晓静. Notch信号通路在黑色素瘤生长、转移中的作用及机制[J]. 国际肿瘤学杂志, 2018, 45(10): 635-638.
[11]	郑佩. Wnt/β-catenin信号通路与肿瘤干细胞[J]. 国际肿瘤学杂志, 2017, 44(11): 853-855.
[12]	蔡晓君,韩丽娟,韦平. 姜黄素抑制MGMT基因表达增强恶性胶质瘤对替莫唑胺化疗的敏感性[J]. 国际肿瘤学杂志, 2016, 43(8): 565-569.
[13]	姜小良, 罗旭, 刘如明. hepaCAM与多药耐药蛋白在肾癌中的表达及相互关系 [J]. 国际肿瘤学杂志, 2016, 43(8): 584-587.
[14]	陈颖，张幸平. 肿瘤多药耐药的逆转措施[J]. 国际肿瘤学杂志, 2016, 43(5): 364-367.
[15]	田若楠，孙剑经，张林西. 姜黄素抗食管癌的机制[J]. 国际肿瘤学杂志, 2016, 43(5): 379-381.